MIB in Shanghai: The strategic role of Clinical Investigation Centers in the evolution of global healthcare
Lors du DIA China Annual Meeting 2025 à Shanghai, le Dr Daniel Olive (Professeur d’immunologie, praticien hospitalier et responsable médical, scientifique et technique de MIB) a participé à la table ronde d’ouverture aux côtés de représentants de Chine, d’Arabie Saoudite et des États-Unis.
Together, they explored the role of clinical investigation centers in the transformation of global healthcare systems.
During this inaugural session, Dr. Olive shared MIB’s vision, emphasizing:
The acceleration of innovation relies on better integration between science, clinical practice, and biotechnology,
The fundamental importance of collaboration to create tangible impact in health,
Europe’s unique position as a strategic bridge in building international scientific alliances.
By participating in this international roundtable, MIB reaffirms its commitment: to make research a real driver of transformation for the benefit of patients.
At a time when global cooperation is more crucial than ever, MIB positions itself as a key player in the scientific dialogue, catalyzing synergies between innovation, clinical practice, and biotechnologies to tackle major health challenges.
Actualités
